Novel roles of phosphoinositides in signaling, lipid transport, and disease
Introduction
Phosphoinositides (PPIns) are lipid signaling molecules that coordinate numerous aspects of membrane trafficking and cell signaling in eukaryotic cells. Their action is essential in cell growth, metabolism, and cell death [1]. The enzymes that modify PPIns (kinases, phosphatases, and lipases) are critically linked to multiple human diseases, with mutations leading to cancer, immune disorders, developmental disorders, and inflammatory diseases [∗2, 3, 4]. There are 7 different PPIn species (Figure 1a), with all of them acting as regulators of temporal and spatial signaling events (Figure 1b). The canonical view of PPIn signaling has focused on their role in both the recruitment (Figure 2a) and allosteric activation of proteins at specific intracellular locations (Figure 2b). PPIn-mediated recruitment of proteins to specific organelles can mark their final destination in membrane trafficking [5], modify biophysical properties of membranes [6], and provide spatial regulation of signaling.
However, recent years have seen an explosion in our understanding of other key roles of PPIns, including their role in modulating integral membrane protein signaling (Figure 2c), and regulating lipid transport (Figure 2d). This review will highlight recent discoveries in PPIn biology, focusing on four specific areas: novel roles of PPIns in signaling, PPIn regulation of integral membrane proteins, how PPIns and lipid transfer proteins mediate lipid exchange against thermodynamic gradients, and finally novel discoveries toward treating human disease by targeting PPIn-metabolizing enzymes. For more comprehensive coverage of PPIn function in, for example, cytoskeletal dynamics and nuclear function, we refer the reader to several recent, comprehensive reviews [7,8].
Section snippets
Noncanonical roles of PPIns in recruitment of cellular signaling machinery
The canonical view of PPIn signaling is the recruitment of specific lipid-binding domains to intracellular membranes, with multiple domains putatively identified as specific PPIn binders (PX, PH, FYVE, etc., for an in-depth review readers are advised to consult [9,10]). The recruitment of these domains to specific intracellular organelles can mediate signaling not only through localization but also through lipid binding–mediated conformational changes [11, 12, 13]. Exhaustive analysis of these
PPIns as regulators of integral membrane protein signaling
The binding of PPIns to integral membrane proteins can modulate their activity and can allow for activation of integral membrane proteins to only occur when they are in specific membrane organelles. PPIns can regulate integral membrane proteins through multiple mechanisms: they can induce allosteric conformational changes and/or mediate coupling to protein binding partners. PPIns have long been known to be key regulators of ion channels, with PI(4,5)P2 identified as a key regulator of channel
PPIns and lipid transfer proteins
Evidence is emerging that lipid transfer proteins (LTPs) can use PPIns in a novel way (Figure 4): as a means to couple the energy of ATP hydrolysis to the transport of lipid cargoes against a concentration gradient at membrane contact sites (MCSs). So far, evidence implicates this mechanism for enrichment of trans-Golgi network (TGN) cholesterol and PM phosphatidylserine (PS) [52,53]. In both cases, members of the oxysterol binding protein–related protein (ORP) family and the PPIn PI4P are
Novel insight into targeting pathological PPIn metabolism in disease
The most clinically advanced strategy targeting pathologies in PPIn signaling has been targeting the PI3K pathway in cancer, immunodeficiencies, and growth disorders. Currently there are four clinically approved PI3K inhibitors [2,∗70, 71, 72, 73]; however, there has been little success in targeting solid tumors with this approach, with various deleterious side effects. Recent discoveries suggest there may be unique additional opportunities to target this pathway in disease. Inhibitors specific
Conclusions and future directions
PPIns are master regulators of signaling in almost every intracellular membrane compartment. The development of novel tools to interrogate PPIn metabolism have revealed exciting new insight into their roles in controlling membrane trafficking, metabolism, autophagy, and signaling. The classical understanding of PPIn signaling was as messengers that could recruit and/or activate soluble effector proteins. As we have seen, our knowledge of the repertoire of such proteins and their associated
Author contributions
JEB and GRVH equally split all writing, including conceptualization, drafting, editing, and generation of figures.
Conflict of interest statement
Nothing declared.
Acknowledgements
Work in the Burke Laboratory is supported by research grants from Canadian Institute of Helath Research (CRN-142393), Natural Science and Engineering Research Council of Canada (Discovery grant 2014-05218), and the Cancer Research Society (CRS 24368) along with salary awards from CIHR (New investigator award) and the Michael Smith Foundation for Health Research (Scholar 17686). Work in the Hammond Laboratory is supported by National Institutes of Health grant 1R35GM119412-01.
References (91)
- et al.
Recurrent PTPRB and PLCG1 mutations in angiosarcoma
Nat Genet
(2014) - et al.
Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids
Biochem J
(2019) - et al.
Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma
Nature
(1998) - et al.
Structure and autoregulation of a P4-ATPase lipid flippase
Nature
(2019) - et al.
Structural insights on TRPV5 gating by endogenous modulators
Nat Commun
(2018) - et al.
Allosteric regulation of G protein-coupled receptor activity by phospholipids
Nat Chem Biol
(2016) - et al.
ORP2 delivers cholesterol to the plasma membrane in exchange for phosphatidylinositol 4, 5-bisphosphate (PI(4,5)P2)
Mol Cell
(2019) - et al.
Aster proteins facilitate nonvesicular plasma membrane to ER cholesterol transport in mammalian cells
Cell
(2018) - et al.
Osh4p exchanges sterols for phosphatidylinositol 4-phosphate between lipid bilayers
J Cell Biol
(2011) - et al.
SAC1 degrades its lipid substrate PtdIns4P in the endoplasmic reticulum to maintain a steep chemical gradient with donor membranes
Elife
(2018)
The activity of Sac1 across ER-TGN contact sites requires the four-phosphate-adaptor-protein-1
J Cell Biol
Mutations in INPP5K, encoding a phosphoinositide 5-phosphatase, cause congenital muscular dystrophy with cataracts and mild cognitive impairment
Am J Hum Genet
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma
N Engl J Med
Effective “Activated PI3Kδ Syndrome-”targeted therapy with the PI3Kδ inhibitor leniolisib
Blood
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway
Science
Tamoxifen therapy in a murine model of myotubular myopathy
Nat Commun
Phosphoinositides: tiny lipids with giant impact on cell regulation
Physiol Rev
Phosphatidylinositol 3-kinase, growth disorders, and cancer
N Engl J Med
Structural basis for regulation of phosphoinositide kinases and their involvement in human disease
Mol Cell
A phosphoinositide conversion mechanism for exit from endosomes
Nature
Efficient Golgi forward trafficking requires GOLPH3-driven, PI4P-dependent membrane curvature
Dev Cell
Nuclear phosphoinositides: their regulation and roles in nuclear functions
Int J Mol Sci
Polyphosphoinositide-binding domains: insights from peripheral membrane and lipid-transfer proteins
Adv Exp Med Biol
Membrane recognition by phospholipid-binding domains
Nat Rev Mol Cell Biol
Lipid-targeting pleckstrin homology domain turns its autoinhibitory face toward the TEC kinases
Proc Natl Acad Sci USA
Achieving a graded immune response: BTK adopts a range of active/inactive conformations dictated by multiple interdomain contacts
Structure
Conformational sampling of membranes by Akt controls its activation and inactivation
Proc Natl Acad Sci USA
Classification of the human phox homology (PX) domains based on their phosphoinositide binding specificities
Nat Commun
Phosphorylation of conserved phosphoinositide binding pocket regulates sorting nexin membrane targeting
Nat Commun
Mutually inhibitory Ras-PI(3,4)P2 feedback loops mediate cell migration
Proc Natl Acad Sci USA
PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
Nature
Phosphoinositide interactions position cGAS at the plasma membrane to ensure efficient distinction between self- and viral DNA
Cell
Intrinsic lipid binding activity of ATG16L1 supports efficient membrane anchoring and autophagy
EMBO J
Regulation of cardiac Na+,Ca2+ exchange and KATP potassium channels by PIP2
Science
Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2
Nature
Structural basis for PtdInsP2-mediated human TRPML1 regulation
Nat Commun
Endothelial GqPCR activity controls capillary electrical signaling and brain blood flow through PIP2 depletion
Proc Natl Acad Sci USA
PIP2 depletion promotes TRPV4 channel activity in mouse brain capillary endothelial cells
Elife
Selective binding of a toxin and phosphatidylinositides to a mammalian potassium channel
Nat Commun
PtdIns(4,5)P2 stabilizes active states of GPCRs and enhances selectivity of G-protein coupling
Nature
Epsin and Sla2 form assemblies through phospholipid interfaces
Nat Commun
Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer
Nature
Human SEIPIN binds anionic phospholipids
Dev Cell
Structural insights into the voltage and phospholipid activation of the mammalian TPC1 channel
Nature
Cryo-electron microscopy structure of the lysosomal calcium-permeable channel TRPML3
Nature
Cited by (106)
Intracellular trafficking of HIV-1 Gag via Syntaxin 6-positive compartments/vesicles: Involvement in tumor necrosis factor secretion
2024, Journal of Biological ChemistryExploiting pancreatic cancer metabolism: challenges and opportunities
2024, Trends in Molecular MedicineActin-binding protein profilin1 is an important determinant of cellular phosphoinositide control
2024, Journal of Biological ChemistryA new role for phosphoinositides in regulating mitochondrial dynamics
2024, Advances in Biological RegulationPhosphoinositides take a central stage in regulating blood platelet production and function
2024, Advances in Biological RegulationStructural basis for the conserved roles of PI4KA and its regulatory partners and their misregulation in disease
2023, Advances in Biological Regulation